Global Needle-free Drug Delivery Technologies market 2015-2019

ニードルフリー(無針)ドラッグデリバリー製品の世界市場:ジェットインジェクター、経皮吸収パッチ

◆タイトル:Global Needle-free Drug Delivery Technologies market 2015-2019
◆商品コード:IRTNTR4938
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2014年12月24日
◆ページ数:116
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Five UserUSD3,300 ⇒換算¥372,900見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、ニードルフリー(無針)ドラッグデリバリー製品の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、ニードルフリー(無針)ドラッグデリバリー製品の世界市場規模及び予測、用途別分析、製品別分析、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

・エグゼクティブサマリー
・市場概観
・業界の構造分析
・ニードルフリー(無針)ドラッグデリバリー製品の世界市場:市場規模及び予測
・ニードルフリー(無針)ドラッグデリバリー製品の世界市場:用途別分析
・ニードルフリー(無針)ドラッグデリバリー製品の世界市場:製品別分析
・ニードルフリー(無針)ドラッグデリバリー製品の世界市場:地域別分析
・市場シェア
・購買基準
・市場成長要因
・市場の課題
・市場動向
・競争状況
・主要企業(ベンダー)分析
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

About Needle-free Drug Delivery Technology
Needle-free drug delivery technologies are used to deliver drugs or vaccines into a patient’s body without the need for a traditional needle. The primary objectives of the development of these technologies are to eliminate NSI and its associated complications and increase patient compliance and comfort. Needle-free drug delivery systems include jet injectors, microneedles, nanopatches, and vaccine implants. The advantages of these systems over conventional syringes are expanded immunization coverage, decreased healthcare costs, and increased patient compliance. Needle-free systems expand the range of molecules that can be delivered transdermally with improved efficiency and enhance the efficacy of the drug or vaccine. Microneedles increase the efficacy of vaccines by targeting them to antigen-presenting cells mainly found just beneath the stratum corneum of the skin.

TechNavio’s analysts forecast the Global Needle-free Drug Delivery Technologies market to grow at a CAGR of 13.50 percent over the period 2014-2019.

[Covered in this Report]
This report covers the present scenario and the growth prospects of the Global Needle-free Drug Delivery Technologies market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various needle-free drug delivery systems with active mechanisms for skin permeation such as velocity, ultrasound, iontophoresis, thermo ablation, and electrophoresis. This mode of drug delivery includes:
• Jet Injectors
• Transdermal Patches (Microneedles, Nanopatches)

TechNavio’s report, the Global Needle-free Drug Delivery Technologies Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Needle-free Drug Delivery Technologies market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• 3M
• Antares Pharma
• Bioject Medical Technologies
• Glide Pharmaceutical Technologies
• PharmaJet
• Zogenix

[Other Prominent Vendors]
• Akra Dermojet
• Alkermes
• Alza
• Anthony Products
• Aradigm
• Bespak
• BioValve Technologies
• Crossject
• D’Antonio Consultants International
• European Pharma Group
• Evonik Industries
• Iomai
• Injex Pharma
• Lohmann Therapie-Systeme
• Medical International Technologies
• Merck
• National Medical Products
• Nemaura
• Neolabs Solutions
• Pacira Pharmaceuticals
• Penjet
• Spirit Healthcare
• Valeritas
• Zosano
• Zynerba Pharmaceuticals

[Market Driver]
• Increased Safety Concerns
• For a full, detailed list, view our report

[Market Challenge]
• Technical Issues
• For a full, detailed list, view our report

[Market Trend]
• Mandatory Use of Safety Injection Practices
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.NSIs – A Global Burden
06.1.1 A Temporary Solution

07.Needle-free Drug Delivery Technologies
07.1 A Sustainable Solution
07.2 Advantages
07.3 ISO 21649-2006
07.4 Latest Developments

08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis

09.Market Segmentation by Product Type

10.Global Jet Injectors Market
10.1 Market Overview
10.1.1 Product Portfolio
10.2 Market Size and Forecast

11.Global Transdermal Patches Market
11.1 Market Overview
11.1.1 Product Portfolio
11.1.2 Market Size and Forecast
11.2 Global Microneedles Market
11.2.1 Market Overview
11.2.2 Market Size and Forecast
11.3 Global Nanopatches Market
11.3.1 Market Overview
11.3.2 Market Size and Forecast

12.Market Segmentation by Application
12.1 Global Insulin Delivery Market
12.1.1 Market Size and Forecast
12.2 Global Vaccines Market
12.2.1 Market Size and Forecast
12.3 Global Pediatric Injections Market
12.3.1 Market Size and Forecast

13.Geographical Segmentation

14.Buying Criteria

15.Market Growth Drivers

16.Drivers and their Impact

17.Market Challenges

18.Impact of Drivers and Challenges

19.Market Trends

20.Trends and their Impact

21.Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2014
21.3 Other Prominent Vendors

22.Key Vendor Analysis
22.1 3M
22.1.1 Key Facts
22.1.2 Business Description
22.1.3 Business Segmentation
22.1.4 Revenue by Business Segmentation
22.1.5 Revenue Comparison 2013 and 2014
22.1.6 Sales by Geography
22.1.7 Business Strategy
22.1.8 Key Developments
22.1.9 SWOT Analysis
22.2 Antares Pharma
22.2.1 Key Facts
22.2.2 Business Description
22.2.3 Business Segmentation
22.2.4 Revenue by Business Segmentation
22.2.5 Revenue Comparison 2013 and 2014
22.2.6 Sales by Geography
22.2.7 Business Strategy
22.2.8 Key Developments
22.2.9 SWOT Analysis
22.3 Bioject Medical Technologies
22.3.1 Key Facts
22.3.2 Business Description
22.3.3 Business Segmentation
22.3.4 Revenue by Business Segmentation
22.3.5 Revenue Comparison 2013 and 2014
22.3.6 Sales by Geography
22.3.7 Business Strategy
22.3.8 Key Developments
22.3.9 SWOT Analysis
22.4 Glide Pharmaceutical Technologies
22.4.1 Key Facts
22.4.2 Business Description
22.4.3 Business Segmentation
22.4.4 Revenue by Business Segmentation
22.4.5 Revenue Comparison 2013 and 2014
22.4.6 Sales by Geography
22.4.7 Business Strategy
22.4.8 Key Developments
22.4.9 SWOT Analysis
22.5 PharmaJet
22.5.1 Key Facts
22.5.2 Business Description
22.5.3 Business Segmentation
22.5.4 Revenue by Business Segmentation
22.5.5 Revenue Comparison 2013 and 2014
22.5.6 Sales by Geography
22.5.7 Business Strategy
22.5.8 Key Developments
22.5.9 SWOT Analysis
22.6 Zogenix
22.6.1 Key Facts
22.6.2 Business Description
22.6.3 Business Segmentation
22.6.4 Revenue by Business Segmentation
22.6.5 Revenue Comparison 2013 and 2014
22.6.6 Sales by Geography
22.6.7 Business Strategy
22.6.8 Key Developments
22.6.9 SWOT Analysis

19.Other Reports in this Series

[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Executive Summary of Global Needle-free Drug Delivery Technologies Market 2014-2019
Exhibit 3: NSIs – Facts and Figures
Exhibit 4: Percentage of NSIs at Different Stages of the Injection Process
Exhibit 5: Percentage of Professionals Exposed to NSIs
Exhibit 6: Various Needle-free Drug Delivery Systems
Exhibit 7: Benefits of Needle-free Drug Delivery Devices
Exhibit 8: Disadvantages of Needle-free Drug Delivery Devices
Exhibit 9: Latest Developments by WHO
Exhibit 10: Global Needle-free Drug Delivery Technologies Market 2014-2019 (US$ million)
Exhibit 11: Global Needle-free Drug Delivery Technologies Market Segmentation by Product Type
Exhibit 12: Revenue (US$ million) and CAGR Comparison of Global Needle-free Drug Delivery Technologies Market Segments 2014 and 2019
Exhibit 13: Snapshot of Global Needle-free Drug Delivery Technologies Market Segmentation by Product Type 2014-2019
Exhibit 14: Global Needle-free Drug Delivery Technologies Market Segmentation by Product Type 2014-2019 (US$ million)
Exhibit 15: Global Needle-free Drug Delivery Technologies Market Segmentation by Product Type 2014
Exhibit 16: Global Needle-free Drug Delivery Technologies Market Segmentation by Product Type 2014 and 2019 (in percent)
Exhibit 17: Global Needle-free Drug Delivery Technologies Market Segmentation by Product Type 2014-2019
Exhibit 18: YoY Growth Rate of Global Needle-free Drug Delivery Technologies Market Segments 2014-2019
Exhibit 19: Components of Needle-free Jet Injector
Exhibit 20: Ideal Characteristics of a Jet Injector
Exhibit 21: Advantages of Jet Injectors
Exhibit 22: Global Jet Injectors Market 2014-2019 (US$ million)
Exhibit 23: Global Transdermal Patches Market Segmentation by Product Type
Exhibit 24: Global Transdermal Patches Market Segmentation by Product Type 2014-2019 (US$ million)
Exhibit 25: Global Transdermal Patches Market Segmentation by Product Type 2014 and 2019
Exhibit 26: Global Transdermal Patches Market Segmentation by Product Type 2014-2019
Exhibit 27: Yoy Growth Rate of Global Transdermal Patches Market Segments 2014-2019
Exhibit 28: Global Transdermal Patches Market 2014-2019 (US$ million)
Exhibit 29: Comparison of Syringe and Microneedle Drug Administration
Exhibit 30: Types of Microneedles
Exhibit 31: Silicon Microneedles
Exhibit 32: Metal Microneedles
Exhibit 33: Advantages of Microneedles
Exhibit 34: Disadvantages of Microneedles
Exhibit 35: Global Microneedles Market 2014-2019 (US$ million)
Exhibit 36: Global Nanopatches Market 2014-2019 (US$ million)
Exhibit 37: Global Needle-free Drug Delivery Technologies Market Segmentation by Application
Exhibit 38: Global Needle-free Drug Delivery Technologies Market Segmentation by Application 2014
Exhibit 39: Revenue (US$ million) and CAGR Comparison of Global Needle-free Drug Delivery Technologies Market Segments by Application 2014 and 2019
Exhibit 40: Global Needle-free Drug Delivery Technologies Market Segmentation by Application 2019
Exhibit 41: Global Needle-free Drug Delivery Technologies Market Segmentation by Application 2014-2019 (US$ million)
Exhibit 42: Global Needle-free Drug Delivery Technologies Market Segmentation by Application 2014-2019
Exhibit 43: Global Insulin Delivery Market 2014-2019 (US$ million)
Exhibit 44: Global Vaccines Market 2014-2019 (US$ million)
Exhibit 45: Global Pediatric Injections Market 2014-2019 (US$ million)
Exhibit 46: Global Needle-free Drug Delivery Technologies Market Segmentation by Geography 2014
Exhibit 47: Buying Criteria of Global Needle-free Drug Delivery Technologies Market 2014
Exhibit 48: Drivers of Global Needle-free Drug Delivery Technologies Market
Exhibit 49: Challenges of Global Needle-free Drug Delivery Technologies Market
Exhibit 50: Bioject: Needle-free Drug Delivery Pipeline Portfolio
Exhibit 51: 3M: Business Segmentation 2014
Exhibit 52: 3M: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 53: 3M: Sales by Geography (in US$ million)
Exhibit 54: Celgene: Business Segmentation by Revenue 2013 and 2014
Exhibit 55: Celgene: Sales by Geography 2014 (Pharmaceuticals Division)
Exhibit 56: Celgene: Sales by Geography 2014 (Diagnostics Division)
Exhibit 57: Bioject: Business Segmentation by Revenue 2014
Exhibit 58: Bioject: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 59: Bioject: Sales by Geography 2014
Exhibit 60: Glide Pharmaceutical Technologies: Business Segmentation
Exhibit 61: Glide Pharmaceutical Technologies: Revenue by Business Segmentation 2014
Exhibit 62: Glide Pharmaceutical Technologies: Revenue by Business Segmentation 2013 and 2014 (US$ million)
Exhibit 63: Glide Pharmaceutical Technologies: Revenue by Geographical Segmentation 2014
Exhibit 64: PharmaJet: Business Segmentation by Revenue 2014
Exhibit 65: PharmaJet: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 66: PharmaJet: Sales by Geography 2014
Exhibit 67: Zogenix: Business Segmentation by Revenue 2014
Exhibit 68: Zogenix: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 69: Zogenix: Sales by Geography 2014



【掲載企業】

3M , Antares Pharma, Bioject Medical Technologies , Glide Pharmaceutical Technologies, PharmaJe, Zogenix, Akra Dermojet, Alkermes, Alza, Anthony Products, Aradigm , Bespak, BioValve Technologies, Crossject, D’Antonio Consultants International, European PharmaGroup, Evonik Industries, Iomai , Injex Pharma, Lohmann Therapie-Systeme, Medical International Technologies, Merck , National Medical Products, Nemaura, Neolabs Solutions, Pacira Pharmaceuticals , Penjet, Spirit Healthcare, Valeritas, Zosano, ZynerbaPharmaceuticals

【資料のキーワード】

ニードルフリー(無針)ドラッグデリバリー、薬物伝達システム、ジェットインジェクター、経皮吸収パッチ、薬剤、技術

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[ニードルフリー(無針)ドラッグデリバリー製品の世界市場:ジェットインジェクター、経皮吸収パッチ]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆